Biosimilars: what’s in a name?

The way a biosimilar is named may affect whether a pharmacist is willing to substitute it for a brand name biologic, a new study has found.The study, published in the Journal of Managed Care and Specialty Pharmacy, examined pharmacist perceptions of biosimilar naming conventions and their impact on confidence to dispense biosimilars.It also looked at